Julia is the Laboratory Manager for the Chappell Group, managing the Rapid Response Vaccine Pipeline, Vicebio and Antibody Discovery teams. Julia is a researcher with experience in Parasitology, Virology and Bioinformatics. In her role as Lab Manager she is responsible for resourcing and purchasing, budget planning, and management. Julia ensures that the Chappell Group is compliant with all safety legislation including chemical safety, biological hazards and dealings relating to IBC and OGTR.


Master of Philosophy (Molecular Parasitology), University of Melbourne

Bachelor of Science (Honours, Environmental Biology), The University of Adelaide

Bachelor of Science (Molecular Biology and Immunology, Environmental Science), The University of Adelaide

Key Publications

Chappell, K. J., Mordant, F. L., Li, Z., Wijesundara, D. K., Ellenberg, P., Lackenby, J. A., ... & Munro, T. P. (2021). Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet Infectious Diseases, 21(10), 1383-1394.

Watterson, D., Wijesundara, D.K., Modhiran, N., Mordant, F.L., Li, Z., Avumegah, M.S., McMillan, C.L., Lackenby, J., Guilfoyle, K., van Amerongen, G. and Stittelaar, K., 2021. Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2. Clinical & translational immunology, 10(4), p.e1269.

Wijesundara, D. K., Avumegah, M. S., Lackenby, J., Modhiran, N., Isaacs, A., Young, P. R., ... & Chappell, K. J. (2020). Rapid response subunit vaccine design in the absence of structural information. Frontiers in Immunology, 11, 592370.

Lackenby, J. A., Chambers, C. B., Ernst, I., & Whittington, I. D. (2007). Effect of water temperature on reproductive development of Benedenia seriolae (Monogenea: Capsalidae) from Seriola lalandi in Australia. Diseases of aquatic organisms, 74(3), 235-242.

Gauci, C. G., Jayashi, C. M., Gonzalez, A. E., Lackenby, J., & Lightowlers, M. W. (2012). Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigens. Vaccine, 30(26), 3824-3828.

Featured projects Duration
Rapid Response Vaccine Pipeline